A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease-Reference-Cited by-同舟云学术

A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease

Published:2019-03-22 Issue:1 Volume:4 Page:
ISSN:2059-0105
Container-title:npj Vaccines
language:en
Short-container-title:npj Vaccines

Author:

Portillo Susana,Zepeda Brenda G.,Iniguez Eva,Olivas Janet J.,Karimi Nasim H.,Moreira Otacilio C.,Marques Alexandre F.,Michael Katja,Maldonado Rosa A.,Almeida Igor C.^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Institute on Minority Health and Health Disparities

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences

U.S. Department of Health & Human Services | DHHS Office of the Secretary

Dr. Keelung Hong Graduate Research Fellowship UTEP Dodson Research Grant

Diana Natalicio Doctoral Dissertation Fellowship

UTEP BUILDing Scholars Program

Frank B. Cotton Trust Scholarship

UTEP College of Science Multidisciplinary Pilot Projects and Collaborations Grant

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology

Link

http://www.nature.com/articles/s41541-019-0107-7.pdf

Reference94 articles.

1. Bern, C. Chagas' disease. N. Engl. J. Med. 373, 456–466 (2015).

2. Rassi, A. Jr, Rassi, A. & Marin-Neto, J. A. Chagas disease. Lancet 375, 1388–1402 (2010).

3. Urbina, J. A. Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives. J. Eukaryot. Microbiol. 62, 149–156 (2015).

4. Ribeiro, I. et al. New, improved treatments for Chagas disease: from the R&D pipeline to the patients. PLoS Negl. Trop. Dis. 3, e484 (2009).

5. Beaumier, C. M. et al. Status of vaccine research and development of vaccines for Chagas disease. Vaccine 34, 2996–3000 (2016).

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatments and the Perspectives of Developing a Vaccine for Chagas Disease;Vaccines;2024-08-01

2. Protective Efficacy of the Epitope-Conjugated Antigen N-Tc52/TSkb20 in Mitigating Trypanosoma cruzi Infection through CD8+ T-Cells and IFNγ Responses;Vaccines;2024-06-04

3. Influence of microbiota-driven natural antibodies on dengue transmission;Frontiers in Immunology;2024-03-15

4. Vaccination with parasite-specific TcTASV proteins combined with recombinant baculovirus as a delivery platform protects against acute and chronic Trypanosoma cruzi infection;Frontiers in Cellular and Infection Microbiology;2024-02-28

5. An α-Gal antigenic surrogate as a biomarker of treatment evaluation in Trypanosoma cruzi-infected children. A retrospective cohort study;PLOS Neglected Tropical Diseases;2024-01-18